Recent Finacing
Recent Raise
Concentric Analgesics is a clinical-stage biopharmaceutical company developing TRPV1-agonist prodrug therapeutics, including CA-008 (vocacapsaicin) for single-administration, long-lasting postsurgical and chronic pain relief.